3 Drugmakers Not Pleased With Amarin's Fish Oil Triumph

3 Drugmakers Not Pleased With Amarin's Fish Oil Triumph

Source: 
Yahoo/Motley Fool
snippet: 

Results that show Amarin Corporation's (NASDAQ: AMRN) Vascepa brand of fish oil succeeded where similar attempts failed are terrific news for millions of patients at risk of heart attacks and strokes. It could also be great news for their insurers that don't want to cover pricey cholesterol drugs from Amgen, Inc. (NASDAQ: AMGN)Sanofi (NYSE: SNY), and Regeneron (NASDAQ: REGN)